SMARCA4缺陷型胸部肉瘤的影像学特征:21例患者的多中心研究
该多中心研究回顾2011年6月至2017年5月2家法国肉瘤参考中心经组织学证实的21例成人SMARCA4缺陷型胸部肉瘤(SMARCA4-DTS)患者的胸部CT,总结出纵隔、胸膜、颈部及腹膜后四种主要影像模式,特征包括边界不清、不均匀强化、多腔隙延伸、压迫性肺不张、血管包绕及坏死性淋巴结病,中位总生存期5个月。
要点
- SMARCA4-DTS多见于有吸烟史的中青年男性,中位年龄48岁,男性占85.7%。
- 原发肿瘤中位大小120 mm,全部21例边界不清,20例增强后不均匀强化。
- 19例见坏死性淋巴结病,13例伴周围浸润,转移以肾上腺、肺、骨为主。
核心结论
- 多数SMARCA4-DTS表现为压迫性和浸润性胸部肿块伴边界不清的坏死性淋巴结病,放射科医生应将其纳入鉴别诊断,尤其对年轻吸烟男性的快速进展性胸部肿块。
研究设计与样本
- 多中心研究,纳入2011年6月至2017年5月2家法国肉瘤参考中心经组织学证实的21例成人SMARCA4-DTS患者,均有至少一次胸部CT,并回顾病理、分子分析及患者结局。
关键影像表现/征象
- 按主要肿瘤负荷位置分为纵隔型(13例)、胸膜型(6例)、颈部型(1例)和腹膜后型(1例)四种影像模式。
- 原发肿瘤中位大小120 mm(范围46-266 mm),21例边界不清,20例增强后不均匀强化。
- 20例见从纵隔向肺尖、胸膜或颈部多腔隙延伸,11例见压迫所致肺不张,16例见血管包绕(其中5例上腔静脉综合征),5例见食管侵犯。
- 8例行PET-CT者原发肿瘤显示强18F-FDG摄取。
- 19例见坏死性淋巴结病,13例伴周围浸润;基线转移主要位于肾上腺(10例)、肺(6例)和骨(5例)。
临床应用与阅片要点
- 作者认为SMARCA4-DTS应纳入放射科医生的鉴别诊断,尤其面对年轻吸烟男性的快速进展性胸部肿块时。
- 阅片时注意边界不清、不均匀强化、多腔隙延伸、血管包绕及坏死性淋巴结病等特征。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: SMARCA4-deficient thoracic sarcoma (SMARCA4-DTS) is a recently identified aggressive subtype of sarcoma. The aim of this study was to characterize the CT imaging features of SMARCA4-DTS.
METHODS: From June 2011 to May 2017, 21 adult patients with histologically proven SMARCA4-DTS were identified in the radiological database of 2 French sarcoma reference centers with at least one chest CT scan available. The locations, sizes, heterogeneity, margin definitions, and local extensions of the tumors were reported together with their impact on surrounding organs and regional and distant metastases. Pathological findings, molecular analyses, and patients' outcomes were retrieved.
RESULTS: Of the 21 included patients (median age 48, range 30-74), 18 (85.7%) were male and 18 (85.7%) had a smoking history. Four main radiological patterns were identified depending on the location of the main tumor burden: mediastinal (n = 13), pleural (n = 6), cervical (n = 1), and retroperitoneal (n = 1). Median size was 120 mm (range 46-266). Characteristic CT imaging features of primary tumors included ill-defined margins (n = 21), heterogeneous enhancement after injection (n = 20), multi-compartment extension from mediastinum to lung apex, pleura, or neck (n = 20), compressive effect responsible for atelectasis (n = 11), vascular encasement (n = 16-5 superior vena cava syndrome), and esophagus invasion (n = 5). Primary tumors showed strong 18F-FDG avidity in eight patients with PET-CT. Necrotic lymphadenopathies were found in 19 patients, with a surrounding infiltrate in 13 patients. Metastatic locations at baseline mainly involved adrenal (n = 10), lung (n = 6), and bone (n = 5). Median overall survival was 5 months (range 1-13).
CONCLUSION: Most SMARCA4-DTS present with compressive and infiltrative chest masses with ill-defined necrotic lymphadenopathies. The diagnosis of SMARCA4-DTS should enter in the differentials of the radiologist, especially in the case of a rapidly evolving thoracic mass in young smoking males.
KEY POINTS: • SMARCA4-DTS is a very aggressive poorly differentiated sarcoma with a predilection for young and middle-aged adult male smokers. • SMARCA4-DTS, which is mostly located in the chest cavity, can compress and infiltrate all adjacent organs leading to superior vena syndrome, lung atelectasis, epiduritis, spinal cord compression, and esophagus invasion. • SMARCA4-DTS typically demonstrates several ill-defined necrotic lymphadenopathies spreading in axillar, subclavian, cervical, mediastinum, and retroperitoneum.
引用
- Crombé A, Alberti N, Villard N, et al. Imaging features of SMARCA4-deficient thoracic sarcomas: a multi-centric study of 21 patients. Eur Radiol. 2019. PMID: 30762113. doi:10.1007/s00330-019-06017-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。